Patent · US Active

Modified 4′-nucleosides as antiviral agents

US8569478B2 · kind B2 · utility

29Cited by

18References

7Claims

0Family size

Assignee

Gilead Pharmasset LLC · US

Inventors

Jinfa Du · New Hope, US
Phillip A. Furman · Durham, US
Michael Joseph Sofia · Carmel, US

Key dates

Filing date	Sep 26, 2006
Grant date	Oct 29, 2013
Priority date	—
Expiry date	Feb 20, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H19/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds, methods and compositions for treating a host infected with human immunodeficiency virus and hepatitis B virus comprising administering an effective amount of a described 4′-C-substituted β-D- and β-L-nucleoside or a pharmaceutically acceptable salt or prodrug thereof, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.